2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile has been researched along with Angina Pectoris in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Metelitsa, VI; Nikolenko, SA; Piotrovskii, VK; Riabokon, OS; Rumiantsev, DO | 1 |
1 other study(ies) available for 2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile and Angina Pectoris
Article | Year |
---|---|
Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Half-Life; Humans; Kinetics; Male; Middle Aged; Nitriles; Regression Analysis; Verapamil | 1986 |